chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Malaise
Clinical narrative: Headache - shooting pain in the back of head; Feeling unwell; This is a spontaneous report from a non-contactable consumer (patient). A 52-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiry dates were not reported), via an unspecified route of administration, administered in Arm Right on 04Mar2021 at 08:45 (at the age of 52-year-old) as a single dose for COVID-19 immunisation. The patient's medical history included had issue with knee pain in both knees. Patient's concomitant medications included meloxicam at 7.5 mg once daily and gabapentin; both were taken for an unspecified indication, start and stop dates were not reported. On 04Mar2021 at 09:00, the patient experienced headache - shooting pain in the back of head and was feeling unwell. It was reported that no other vaccine taken in four weeks of vaccination. Patient not had COVID-19 prior vaccination; not tested for COVID-19 post vaccination. Patient was not received treatment for the events. The outcome of events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 47.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Headache, Nausea
Clinical narrative: He has a major headache; dizziness; nausea; This is a spontaneous report from a contactable consumer. A 47-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration in right arm, on 01Mar2021 at 14:15, as single dose, for COVID-19 immunization. The patient medical history and concomitant medication were not reported. No vaccine was taken in four weeks. Prior the vaccination, was not diagnosis with COVID-19. post vaccination, no COVID test was performed. On 01Mar2021 at 14:30, patient experienced major headache, dizziness and nausea. No treatment was received for the events. The outcome of the events was reported as not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: M
Vaccine: COVID19
Symptoms: Headache, Tinnitus
Clinical narrative: headaches; tinnitus; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date as 1ST DOSE, SINGLE for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced headaches, and tinnitus on an unspecified date. The outcome of event was unknown.  Information about lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: pressure headache in the lower part of her skull; This is a spontaneous report from a non-contactable consumer (patient) via Medical information team. An 82-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiration date was not reported), via an unspecified route of administration on an unspecified date as unknown single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient states her family member received the first dose of the vaccine 8 days ago. Patient states immediately after the vaccine her family member did not have an adverse reaction, patient had a pressure headache in the lower part of her skull on an unspecified date. Patient states this has happened every day since and gotten worse since the first day and it is now the eighth day. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 71.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Neck pain
Clinical narrative: sore neck started 4 days later; This is a spontaneous report from a contactable consumer or other non hcp. A 71-years-old female (non-pregnant) patient received second dose of bnt162b2 ((Pfizer-BioNTech COVID-19 mRNA vaccine, Formulation: Solution for injection, Batch/Lot Number: EL9262), via an unspecified route of administration, administered in Arm Left on 28Jan2021 15:45 as single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. Patient received first dose of bnt162b2 ((Pfizer-BioNTech COVID-19 mRNA vaccine, Formulation: Solution for injection, Batch/Lot Number: EL3246), via an unspecified route of administration, administered in Arm Left on 08Jan2021 15:15 as single dose for covid-19 immunization. COVID vaccine details: product-COVID 19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested for COVID-19 since the vaccination. The patient had no known allergies to medications, food, or other products. Patient stated that two days after first vaccine she got a sore area right side of her neck probably lymph node area took acetaminophen and used a heating pad for relief-went away 2 days later. Following the 2nd vaccine-sore neck started 4 days later (01Feb2021) and lasted 6 days-this time back of neck-right side. The outcome of the event was recovered on 03Feb2021. No treatment had taken for AE.
Age: 18.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Cough, Fatigue, Headache, Pyrexia
Clinical narrative: Cough; Headache; Fever; Chills; Fatigue; This is a spontaneous report from a contactable consumer (patient herself). An 18-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection), via an unspecified route of administration in right arm on 28Feb2021 at 11:30 (at the age of 18-year-old) as a single dose for COVID-19 immunization. The patient's medical history included known allergies: Nuts, shellfish, sesame. Concomitant medication included etonogestrel (NEXPLANON), received within two weeks of vaccination. The patient did not receive other vaccine in four weeks. No COVID prior vaccination. The patient has not been tested for COVID post vaccination. On 28Feb2021 at 14:00, the patient experienced headache, fever, chills, fatigue. Cough on day 4 (04Mar2021). No treatment medication was received for the adverse events. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: little tiredness; This is a spontaneous report from a contactable consumer (patient) via Pfizer-sponsored program .  A 77-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE;lot unknown), via an unspecified route of administration on 22Feb2021 at single dose for covid-19 immunisation . The patient medical history and concomitant medications were not reported.  The patient experienced little tiredness on an unspecified date in 2021 with outcome of unknown.No follow-up attempts are possible; information about lot/batch number cannot been obtained
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Musculoskeletal stiffness
Clinical narrative: Headache; Stif arm; This is a spontaneous report from a contactable consumer (patient) via a Pfizer sponsored program. A 70-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, (Batch/Lot number was not reported), via an unspecified route of administration on unspecified date as 1st dose, single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. The patient experienced headache, stiff arm on an unspecified date. The patient also verbally stated that she has cataracts in both of her eyes. It was verbally stated as she do not have the mobility she had before. The patient also stated that she will be getting a blood transfusion, and she sees both a cardiologist as well as a kidney doctor. The events were assessed as non-serious. The outcome of the events was reported as unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Diarrhoea, Nasopharyngitis, Nausea
Clinical narrative: cold; joint pain/severe joint pain; severe joint pain; chills; nausea; diarrhea; This is a spontaneous report from a Pfizer-sponsored Program from a contactable consumer (patient)   A female patient of an unspecified age received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration on 19Feb2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation  .  The patient medical history was not reported.     The patient's concomitant medications were not reported.  The patient experienced cold (non-serious) on an unspecified date with outcome of unknown , joint pain/severe joint pain (non-serious) on an unspecified date with outcome of unknown , chills  (non-serious) on an unspecified date with outcome of unknown , nausea  (non-serious) on an unspecified date with outcome of unknown , diarrhea  (non-serious) on an unspecified date with outcome of unknown. She wanted  to know if that was normal and confirm if was safe to get the second.  No follow-up attempts are possible; information about lot/batch number cannot been obtained
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue
Clinical narrative: joint pain; tiredness; This is a spontaneous report from a Pfizer sponsored program.  A contactable male consumer (patient) of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as single dose for covid-19 immunisation.  The patient medical history was not reported. The patient's concomitant medications were not reported.  The patient experienced joint pain and tiredness, non-serious on an unspecified date with outcome of unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: severe migraine; This is a spontaneous report from a contactable consumer (patient) via Pfizer Sponsored program.  A 69-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot unknown), at single dose via an unspecified route of administration on 22Feb2021 for covid-19 immunisation. The patient medical history was not reported. There were no concomitant medications.  The patient experienced severe migraine which she never felt before on an unspecified date in Feb2021 with outcome of unknown.  Took Tylenol already, and asked if she can still take some more. No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lethargy
Clinical narrative: Extreme headache; lethargy; This is a spontaneous report received from a contactable consumer (patient). A 52-year-old female non-pregnant patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6203), via an unspecified route on the left arm on 28Feb2021 as 2nd dose single for COVID-19 immunization. Medical history included osteoporosis and hypothyroidism. Concomitant medications included levothyroxine, alendronate sodium, vitamin D NOS and melatonin. Historical vaccine included first dose of BNT162B2 as a single dose for COVID-19 immunization. Patient has not taken any other vaccine within four weeks. The patient had no COVID-19 prior vaccination and the patient had not been tested for COVID-19 post vaccination. On 28Feb2021, patient experienced extreme headache for 24 hours and lethargy into second day. No treatment was received for the events. The clinical outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Neck pain
Clinical narrative: mild headache; mild neck ache; Fatigue; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received BNT162B2 (BNT162B2), via an unspecified route of administration on 27Feb2021 (Batch/Lot number was not reported) as UNKNOWN, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced mild headache, mild neck ache and fatigue on an unspecified date. Outcome of events was unknown.   Information about lot/batch number has been requested.  Follow-up (13May2021): Follow-up attempts completed. No further information expected.
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Sharp pain in head, right eye area every 3 to 5 minutes; This is a spontaneous report from a contactable consumer (reported for herself). A (58 unit: unknown) non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection),  via an unspecified route of administration, administered in right arm on 03Mar2021 at 13:15 (Batch/Lot number was not reported) as 1st dose, single for Covid-19 immunisation. Patient's medical history and concomitant medication were reported as none. No known allergies were reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any other medication in two weeks prior to the COVID vaccine. The patient did not test COVID-19 positive prior to vaccination. The patient had not been tested for COVID-19 since the vaccination. On 05Mar2021 at 03:45, the patient experienced sharp pain in head, right eye area every 3 to 5 minutes. No treatment was received for the event. The outcome for the event was not recovered.  No follow-up attempts are possible; Information about lot/batch number cannot be obtained.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Prostate examination abnormal
Clinical narrative: Headache; prostate issues; This is a spontaneous report from a contactable consumer. This is Report 2 of 2  A 71-years-old male patient (Husband) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot/Batch number: unspecified, Pfizer NTEC), via an unspecified route of administration on 18Feb2021 as 2nd dose, Single Dose for covid-19 immunization. Medical history and concomitant medications were not reported Family history included, skin cancer and his brother died from skin cancer from an unspecified date. The patient previously took included first dose of BNT162B2 on 28Jan2021 for COVID-19 immunization. No other vaccine in four weeks. The patient was healthy prior to vaccination. No Prior Vaccinations (within 4 weeks). No AE(s) following prior vaccination. The patient's headache happened after the second dose of the vaccine (after 18Feb2021), it started the third day after the vaccine, or something like that. The patient's prostate issue happened after the second day and it lasted a few hours then it was okay the next day. It was not known if the dose of the vaccine that the patient received and believes the patient received both doses in his left arm but isn't sure. The events were assessed as non-serious. No relevant lab tests were reported. No emergency room or physician's office visit required. The outcome was recovered for the events.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache; This is a spontaneous report from a contactable consumer or other non hcp. This consumer reported similar events for 02 patients. This is 2nd of 02 reports.   A 77-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 10Jan2021 (Lot number was not reported) as single dose for COVID-19 immunisation. He received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 31Jan2021 (Lot number was not reported) as single dose for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported.  On an unspecified date, patient experienced headache.  Consumer was not reporting any issue with Pfizer product. Patient did not admit to hospital due to the event. There were no other products that were taken together with those indicated above. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021017655 Same drug/AE, different patient
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Terrible headaches it continued into the following weeks; This is a spontaneous report from a non-contactable consumer (reporting for herself).   A 70-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation solution for injection, Batch/Lot number: unable to locate or read the details), via an unspecified route of administration on an unspecified date (at the age of 70-year-old) as UNKNOWN, SINGLE DOSE for covid-19 immunization. The patient medical history and concomitant medications were not reported. Prior to vaccination, the patient was unknown with diagnosed of COVID-19; Since the vaccination, the patient not been tested for COVID-19. The patient reported that terrible headaches it continued into the following weeks on 23Feb2021. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 34.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Vaccination site reaction
Clinical narrative: Headache; Local site reaction; This is a spontaneous report from a contactable pharmacist (Reporting for himself).   A 34-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number:EL3247), first dose via an unspecified route of administration in left arm on 04Mar2021 09:30 as single dose for covid-19 immunisation at workplace clinic. The patient medical history was reported as none and there was no known allergies. It was reported that patient did not take any vaccination in 4 weeks and no covid test was performed post vaccination. Concomitant medications included cetirizine hydrochloride (ZYRTEC) (Other medications in two weeks). On 04Mar2021 at 15:00, the patient experienced headache and local site reaction. Outcome of the events headache and local site reaction was reported as recovered on an unknown date in Mar2021.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Dysaesthesia, Feeling cold, Heart rate, Heart rate increased, Pain in extremity
Clinical narrative: soreness on her arm; she felt very cold; heart rate went a little fast, recorded at 110-112; felt a weird sensation which she can't fully explain. It was like electrical impulses all over her body started appearing and like her blood is running inside all over her body; could not sleep because of this; This is a spontaneous report from a contactable consumer. A contactable Female Nurse reported for patient. A 60-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date, as 1st dose, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date It was reported that the patient received the 1st dose of the Pfizer vaccine. She was fine afterwards but experienced some soreness on her arm so she took Tylenol. When she got home, she felt very cold but did not have a fever and had a normal temperature. As she was laying down, she felt a weird sensation which she can't fully explain. It was like electrical impulses all over her body started appearing and like her blood is running inside all over her body. Her heart rate went a little fast, recorded at 110-112 while her normal is 100-110. She could not sleep because of this. She woke up and mentioned that her symptoms are lessening, not as intense as they were last night, and there is a little improvement. She took Tylenol for her symptoms and did not go to work. She is glad that it did not get worse. She is concerned because she received the vaccine amidst having a previous COVID Diagnosis last thanksgiving, 27Nov2020. She mentioned that she stayed home and was not hospitalized for it, but experienced intense symptoms for 5 days like the aggressive fever. She went to the CTMD and was given albuterol, tylenol, and mucinex for her symptoms She is glad she survived it but is concerned that she may still have antibodies from her infection and that the vaccine might be interacting with it. She knows that the Pfizer vaccine was not tested in people with previous COVID Diagnosis and just followed the CDC's recommendation to get vaccinated after 90 days after the infection. She is asking for information Pfizer may have on these topics and if she should receive the 2nd dose on 22Mar2021. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: F
Vaccine: COVID19
Symptoms: Sleep disorder
Clinical narrative: soreness on her arm; she felt very cold; heart rate went a little fast, recorded at 110-112; felt a weird sensation which she can't fully explain. It was like electrical impulses all over her body started appearing and like her blood is running inside all over her body; could not sleep because of this; This is a spontaneous report from a contactable consumer. A contactable Female Nurse reported for patient. A 60-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date, as 1st dose, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date It was reported that the patient received the 1st dose of the Pfizer vaccine. She was fine afterwards but experienced some soreness on her arm so she took Tylenol. When she got home, she felt very cold but did not have a fever and had a normal temperature. As she was laying down, she felt a weird sensation which she can't fully explain. It was like electrical impulses all over her body started appearing and like her blood is running inside all over her body. Her heart rate went a little fast, recorded at 110-112 while her normal is 100-110. She could not sleep because of this. She woke up and mentioned that her symptoms are lessening, not as intense as they were last night, and there is a little improvement. She took Tylenol for her symptoms and did not go to work. She is glad that it did not get worse. She is concerned because she received the vaccine amidst having a previous COVID Diagnosis last thanksgiving, 27Nov2020. She mentioned that she stayed home and was not hospitalized for it, but experienced intense symptoms for 5 days like the aggressive fever. She went to the CTMD and was given albuterol, tylenol, and mucinex for her symptoms She is glad she survived it but is concerned that she may still have antibodies from her infection and that the vaccine might be interacting with it. She knows that the Pfizer vaccine was not tested in people with previous COVID Diagnosis and just followed the CDC's recommendation to get vaccinated after 90 days after the infection. She is asking for information Pfizer may have on these topics and if she should receive the 2nd dose on 22Mar2021. Outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: This is a spontaneous report from a contactable Nurse. This Nurse reported for a patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: unknown, Expiration date: unknown), via an unspecified route of administration, on an unspecified date as single dose  for COVID-19 immunisation. Medical history included COVID-19 from Mar2020 to an unknown date. The patient concomitant medications were not reported. Reporter was concerned because some of her co-workers, about 5 of them, had previous COVID diagnosis last March also received the vaccine were fine and experienced only intense headaches and tired for a couple of days on an unspecified date. It was reported that one person, until now had headaches and took tylenol for it. The outcome of the event intense headaches was reported as not recovered and for tiredness it was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Headache
Clinical narrative: intense headaches; tired for a couple of days; This is a spontaneous report from a contactable Nurse. This Nurse reported for a patient of unspecified age and gender received bnt162b2 (BNT162B2, Solution for injection, Lot number: unknown, Expiration date: unknown), via an unspecified route of administration, on an unspecified date for COVID-19 immunization. Reporter was concerned because some of her coworkers, about 5 of them, had previous COVID diagnosis last March also received the vaccine were fine and experienced only intense headaches and tired for a couple of days. She mentioned that one person, until now had headaches and took tylenol for it. The outcome of the event headaches was reported as not recovered and for tired it was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: U
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: intense headaches; This is a spontaneous report from a contactable other health care professional (nurse). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as single dose for covid-19 immunisation. The patient 's medical history and concomitant medications were not reported. It was reported that some of her coworkers, about 5 of them, had previous COVID diagnosis last March also received the vaccine were fine and experienced only intense headaches and tired for a couple of days. She mentioned that one person, until now has headaches and takes tylenol for it. The outcome of event was not recovered.  No follow -up attempt are possible ; information about lot/batch number cannot be obtained.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Headache, Oropharyngeal pain, Pain
Clinical narrative: Headache; Fever; Chills; Body aches; Swollen tongue; Low energy; Sore throat; This is a spontaneous report received from a contactable Other Health Professional. A 35-year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; formulation: Solution for injection, Lot Number and expiration were not reported), via an unspecified route of administration in the left arm on 01Mar2021 at 20:00 (at the age of 35-years-old) as a single dose for COVID-19 immunization. Medical history included High blood pressure. No known allergies reported. Concomitant medications were not reported. The patient did not receive other vaccine four weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced Headache, Fever, Chills, Body aches, Sore throat, Swollen tongue, and Low energy on 02Mar2021 at 20:00. No treatment medications were received for the events. The outcome of the events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Swollen tongue
Clinical narrative: Headache; Fever; Chills; Body aches; Swollen tongue; Low energy; Sore throat; This is a spontaneous report received from a contactable Other Health Professional. A 35-year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; formulation: Solution for injection, Lot Number and expiration were not reported), via an unspecified route of administration in the left arm on 01Mar2021 at 20:00 (at the age of 35-years-old) as a single dose for COVID-19 immunization. Medical history included High blood pressure. No known allergies reported. Concomitant medications were not reported. The patient did not receive other vaccine four weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced Headache, Fever, Chills, Body aches, Sore throat, Swollen tongue, and Low energy on 02Mar2021 at 20:00. No treatment medications were received for the events. The outcome of the events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Lymphadenopathy, Pain in extremity, Pyrexia
Clinical narrative: headache; fever; chills; arm soreness; lymph node enlarged; This is a spontaneous report from a contactable nurse (patient herself). A 62-years-old female patient (not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EN6198) via an unspecified route of administration, in left arm on 04Mar2021 at 09:45 (at 62-years age) as 1st dose, single dose for COVID-19 immunisation. Medical history included high blood pressure. Patient had allergies to penicillin, bee stings, codeine, cheese, nuts. Concomitant medication(s) that patient received in two weeks included verapamil (VERAPAMIL ER); fish oil (FISH OIL); alpha lipoic acid (ALPHA LIPOIC ACID); zinc (ZINC). Patient did not receive any other vaccines within 4 weeks previous to the COVID vaccine. Facility type vaccine was Hospital. Patient had COVID prior vaccination. On 05Mar2021 at 01:00, the patient experienced headache, fever, chills, arm soreness, lymph node enlarged. Since the vaccination, the patient was not tested for COVID-19. Patient did not receive treatment. The outcome of the events was unknown.  No follow-up attempts are possible. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Decreased appetite, Fatigue, Headache, Insomnia
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 64-year-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Batch/Lot number: EN 6205) via an unspecified route of administration, administered in left arm on 02Mar2021 at 16:45 (at the age of 64-year-old) at a single dose for COVID-19 immunization in Public health clinic/veterans administration facility. Medical history included known allergies: sulfa, penicillin. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included (received in two weeks) naproxen sodium (ALEVE), vitamins nos (MULTIVITAMIN) curcuma longa (TURMERIC), ubidecarenone (COQ10), berberis vulgaris root, camellia sinensis leaf extract, coptis chinensis root, curcuma longa rhizome, fallopia japonica root with rhizome, origanum vulgare leaf, rosmarinus officinalis leaf, scutellaria baicalensis root, zingiber officinale rhizome (ZYFLAMEND). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 03Mar2021 at 1:15, the patient had a terrible headache on top of her head- it woke me up the middle of the night and patient could not go back to sleep, body aches, chills, exhausted to the point of missing work, loss of appetite, thirsty, lymph node under left arm (vax site) enlarged. 4 days later (as per report), patient still felt a bit under the weather. Patient did not receive any treatment for the events. The outcome of the events was not recovered. No follow-up attempts are possible. No further information is expected.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Malaise, Pain, Thirst
Clinical narrative: This is a spontaneous report from a contactable consumer (patient). A 64-year-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Batch/Lot number: EN 6205) via an unspecified route of administration, administered in left arm on 02Mar2021 at 16:45 (at the age of 64-year-old) at a single dose for COVID-19 immunization in Public health clinic/veterans administration facility. Medical history included known allergies: sulfa, penicillin. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included (received in two weeks) naproxen sodium (ALEVE), vitamins nos (MULTIVITAMIN) curcuma longa (TURMERIC), ubidecarenone (COQ10), berberis vulgaris root, camellia sinensis leaf extract, coptis chinensis root, curcuma longa rhizome, fallopia japonica root with rhizome, origanum vulgare leaf, rosmarinus officinalis leaf, scutellaria baicalensis root, zingiber officinale rhizome (ZYFLAMEND). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 03Mar2021 at 1:15, the patient had a terrible headache on top of her head- it woke me up the middle of the night and patient could not go back to sleep, body aches, chills, exhausted to the point of missing work, loss of appetite, thirsty, lymph node under left arm (vax site) enlarged. 4 days later (as per report), patient still felt a bit under the weather. Patient did not receive any treatment for the events. The outcome of the events was not recovered. No follow-up attempts are possible. No further information is expected.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Sinusitis
Clinical narrative: Headache going on 3 weeks; Sinus swelling; Dizziness; This is a spontaneous report from a contactable consumer, the patient. A 38-years-old non-pregnant female patient received first dose of BNT162B2 (COMIRNATY, Solution for injection, Lot number unknown) via an unspecified, route of administration in left arm on 14Feb2021 at 03:30 PM (at the age of 38-years-old) as single dose for COVID-19 immunization in Clinic/Veterans. The patient had no allergies, medical history and concomitant medications. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. On 16Feb2021, patient experienced headache (going on 3 from weeks), sinus swelling and dizziness (began at the end of 2nd week). Physician prescribed steroids to the patient. Outcome of the events sinus swelling, and dizziness was unknown while of headache was not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 48.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Nausea
Clinical narrative: Severe headache; Fatigue; Chills; Mild nausea; This is a spontaneous report from a contactable consumer (patient) reported for himself. A 48-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL3248, Expiration Date: unknown) via an unspecified route of administration in left arm on 04Mar2021 (age at vaccination was 48 years) as 1ST DOSE, SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On 04Mar2021, few hours after vaccination, the patient experienced severe headache, fatigue, chills and mild nausea. The facility where the most recent COVID-19 vaccine was administered was Workplace clinic. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No treatment was received for the adverse event. The outcome of the events was not recovered.  No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Chills, Diarrhoea, Feeling abnormal, Headache
Clinical narrative: Headache; Brain fog; Stomach cramps; Diarrhea; Chills; This is a spontaneous report from a contactable consumer. This consumer reported for 59-year-old male patient (age at vaccination: 59 Years) received a dose of (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number and expiry date were not provided), via an unspecified route of administration, on an unknown date, as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. It was reported that the patient had headache, brain fog, stomach cramps, diarrhea, and chills which was started 24 hours after vaccination on 27Feb2021. The patient did not receive any treatment for the adverse events. The reporter responded to the query that the reporter became aware of the occurrence on 01Mar2021. The reporter was not the patient in this case and the patient was not a Pfizer colleague. Outcome of the events was recovered.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Limb discomfort, Urticaria
Clinical narrative: hives around her neck.; dull headache; soreness in arm; This is a spontaneous report from a contactable Nurse (patient, self-reported). A female patient with unspecified age units received of bnt162b2 (PFIZER-BIONTEC COVID-19 VACCINE, Solution for injection, Lot Number and expiry date were not provided), via an unspecified route of administration on 03Mar2021, Wednesday at 10:00, as a single dose for covid-19 immunisation. The patient's medical history and concomitant medication were not reported. On 04Mar2021, yesterday, patient experienced dull headache and soreness in arm. On 05Mar2021, today, the patient experienced hives around her neck. She wants to know if this was reported as a side effect of vaccine. The outcome of event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Illness, Malaise, Nasopharyngitis
Clinical narrative: Could he get the virus from the vaccine; a bad cold and yucky stuff coming out; sick; didn't feel well; This is a spontaneous report from a contactable consumer. A 54-years-old male patient received first dose bnt162b2 (Pfizer-Biontech Covid-19 Vaccine, Solution for injection, batch/lot number EM9809 and expiration date were not reported), via unspecified route on left arm on 25Feb2021 at 10:00 AM at single dose for covid-19 immunization. The patient's medical history was diagnosed myasthenia gravis (six to seven years). The patient's concomitant medications include Mycophenolate four 500 mg pills per day for Myasthenia gravis. On 28Feb2021, the patient had been sick with a bad cold with yucky stuff coming out. He didn't feel well most of the day on Sunday, 28Feb2021. The reporter wanted to know whether the patient could get the virus from the vaccine and should she have him tested. He doesn't have a fever. Information regarding sample of the product available to be returned, if requested was not provided and information regarding packaging sealed and intact was not provided. There was no history of all previous immunization with the Pfizer vaccine considered as suspect and no additional Vaccines administered on same date of the Pfizer suspect. No prior Vaccinations within 4 weeks and no adverse events following prior vaccinations. The outcome of the events was recovering.   No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Hot flush, Hyperhidrosis, Pain in extremity, Tinnitus
Clinical narrative: headache; sweats/hot flashes; sweats/hot flashes; ringing of ears that are still happening 4 days later; arm pain from shot but now seems ok; This is a spontaneous report from a contactable consumer. A 51-years-old female patient reported for herself received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in left arm on 02Mar2021 14:00 (Batch/Lot Number: EN6203) as 1ST DOSE, SINGLE for covid-19 immunisation. The patient medical history was not reported. Concomitant medication(s) included escitalopram oxalate (LEXAPRO); omeprazole (PRILOSEC [OMEPRAZOLE]). The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient had no known allergies. On 03Mar2021, the patient experienced headache, sweats/hot flashes, ringing of ears that were still happening 4 days later, arm pain from shot but now seems okay. The outcome of the events was reported as not recovered.  No follow-up attempts are possible. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Pyrexia, SARS-CoV-2 test
Clinical narrative: This is a spontaneous report from a contactable other HCP (patient herself). A 32-years-old non pregnant female patient received second dose of bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot Number: EN6203, Expiry date: unknown) via an unspecified route of administration in Arm Right on 04Mar2021 at 12:00 PM as 2ND DOSE, SINGLE for COVID-19 immunization. Medical history included shoulder surgery 2/25 from an unknown date and unknown if ongoing. No other vaccines administered within 4 weeks. There was no COVID-19 prior the vaccination. COVID-19 was tested post vaccination (broad qPCR test) on 23Feb2021 as negative. The patient previously received first dose of bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot Number: EZ9266, Expiry date: Unknown) via an unspecified route of administration in left leg on 11Feb2021 at 01:00 PM as 1ST DOSE, SINGLE for COVID-19 immunization. Concomitant medications included acetaminophen and  ibuprofen taken for an unspecified indication, start and stop date were not reported. On 06Mar2021 at 04:00 AM, the patient experienced headache, dizziness and fever. Treatment was not received for the events. The patient underwent lab tests and procedures on 23Feb2021 which included nasal swab test and qPCR test was negative. The outcome of the events was not recovered. No follow-up attempts are possible. No further information is expected.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Hyperhidrosis, Pyrexia
Clinical narrative: headache; violent chills; fever; sweating; fatigue; This is a spontaneous report from a contactable consumer (patient himself).   A 66-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection; Lot Number: unknown) via an unspecified route of administration, administered in the left arm on 26Feb2021 at 16:15 (at the age of 66-year-old) as a single dose for COVID-19 immunization. Medical history included alcoholic liver disease and known allergies: Dye used in MRI imaging. Concomitant medication(s) included azathioprine (AZATHIOPRINE) taken as 50 mg and prednisone (PREDNISONE) taken as 15 mg. The patient did not receive any other vaccines within four weeks. The patient not had COVID prior vaccination. Consumer reported that he had shot on Friday. The patient had no symptoms till 4x24 hours. Later, the patient started with headache then had violent chills for 3 hours followed by fever. The patient was better throughout Wed then started again on wed, thurs, Friday and sat. lasting shorter period of time but with fever following then sweating then fatigue. Concerned by delay in symptoms and that symptoms persist. On 03Mar2021 at 01:00 AM, the patient experienced headache, violent chills, fever, sweating and fatigue. The patient had not tested COVID post vaccination. The patient did not receive any treatment for the events. The clinincal outcome of the events was unknown.  No follow-up attempts are Possible. Information on Lot/batch number cannot be obtained.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: Headache; low-grade fever; This is a spontaneous report from a contactable consumer (patient). A 62-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection; Lot number and expiration date was unknown), via an unspecified route of administration, administered in left arm on 05Mar2021 15:30 as a single dose for covid-19 immunization. Medical history included prostate cancer (underwent radiation treatment). Allergies to medications, food, or other products included penicillin. Concomitant medications included gabapentin, diazepam, naproxen, diclofenac and cyclobarbital, all taken for an unspecified indication from an unknown date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19. On 06Mar2021 10:00, 18hr 30 min, after vaccination, the patient experienced headache & low-grade fever day. The patient took 2 extra strength Acetaminophen as a treatment & headache began to feel lighter. The patient enquired did the treatment adversely affect the effectiveness of the vaccine by taking them. The outcome of the events was resolving.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Fatigue, Feeling abnormal, Headache
Clinical narrative: headache; fatigue; weakness; joint pain; pain and redness at injection site; pain and redness at injection site; fever; fogginess; This is a spontaneous report from a contactable consumer (patient). A 52-years-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EN6198 and Expiry date were not reported) dose 1, via unspecified route of administration, administered in left arm on 03Mar2021 at 17.30, single for COVID-19 immunization. The patient's medical history included a Covid-19, ankylosing spondylitis, hashimoto's thyroiditis, seasonal allergies, dander allergies, indoor allergies, chronic sinusitis, asthma. The patient had allergies with medication prochlorperazine, food chocolate. The patient did not receive any treatment. The patient was not Covid tested post vaccination.The patient took unknown concomitant medications in two weeks. On 03Mar2021 at 07:00 PM(1.30 mins after vaccination), the patient experienced a headache, fatigue, weakness, joint pain, pain and redness at injection site, fever, fogginess. The outcome of events were not recovered.   No follow-up attempts are possible. No further information is expected